|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1994-11-4
|
|
pubmed:abstractText |
To evaluate the efficacy and toxicity of single-agent vinorelbine (VNB), a semisynthetic vinca alkaloid, in patients with breast cancer previously treated with other chemotherapeutic regimens for metastatic disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2094-101
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:7931479-Adult,
pubmed-meshheading:7931479-Aged,
pubmed-meshheading:7931479-Anemia,
pubmed-meshheading:7931479-Antineoplastic Agents,
pubmed-meshheading:7931479-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7931479-Breast Neoplasms,
pubmed-meshheading:7931479-Cyclophosphamide,
pubmed-meshheading:7931479-Drug Administration Schedule,
pubmed-meshheading:7931479-Fluorouracil,
pubmed-meshheading:7931479-Follow-Up Studies,
pubmed-meshheading:7931479-Humans,
pubmed-meshheading:7931479-Italy,
pubmed-meshheading:7931479-Leukopenia,
pubmed-meshheading:7931479-Methotrexate,
pubmed-meshheading:7931479-Middle Aged,
pubmed-meshheading:7931479-Remission Induction,
pubmed-meshheading:7931479-Survival Rate,
pubmed-meshheading:7931479-Vinblastine
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
|
|
pubmed:affiliation |
Department of Radiotherapy and Oncology, St Bortolo Medical Center, Vicenza, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
